i-BrainTech

i-BrainTech occupies a specialized intersection of neurotechnology, sports software, digital health, and performance analytics. Its differentiation is the combination of EEG-based neurofeedback, brain-computer interface capabilities, visualization training, and athlete-specific analytics rather than a conventional wearable, sports-management system, or generic wellness application. The company’s products address four related use cases: cognitive assessment, player development, recovery and return-to-play readiness, and neuroscience-based visualization training. Its reported work with Juventus, Benfica, MLS organizations, and other European football clubs gives it credibility in elite sports environments and creates a potential enterprise distribution channel. The 2023 Innovation of the Year award at the Social Football Summit further supports its visibility within sports technology. Its planned expansion toward an at-home platform could broaden the addressable market, but would likely introduce greater competition from consumer neurofeedback, cognitive-training, and digital-health products.

i-BrainTech’s growth trajectory shows a transition from early research and product formation into funded commercialization. The company was founded in 2019, raised $1.0 million in a pre-seed round on Apr 1, 2020, added $149,934 in seed financing on Jun 22, 2022 with Techstars as lead investor, and closed a further $5.5 million seed round on Nov 21, 2022. Total recorded funding is $6,649,934 across three rounds. Product development has expanded from a brain-impulse-controlled training game into distinct offerings for visualization, player development, recovery, and cognitive assessment. Partnerships with professional football organizations, including Juventus and Benfica, represent an important enterprise-validation inflection point, while the 2025 Juventus North American fans tour partnership indicates continued brand and market-development activity. The company also holds two granted patents and three registered trademarks, supporting an intellectual-property base around brain training and rehabilitation. Its stated move toward a scalable at-home platform could provide a second growth engine beyond elite teams. Still, the public record contains no employee-growth series, revenue figures, later financing, or confirmed launch metrics, so the pace and durability of expansion remain difficult to quantify.